NanoString Technologies Total Assets 2011-2019 | NSTG

NanoString Technologies total assets from 2011 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
NanoString Technologies Annual Total Assets
(Millions of US $)
2018 $148
2017 $137
2016 $126
2015 $93
2014 $102
2013 $64
2012 $37
2011 $25
2010 $0
NanoString Technologies Quarterly Total Assets
(Millions of US $)
Q3 2019 $221
Q2 2019 $233
Q1 2019 $221
Q4 2018 $148
Q3 2018 $151
Q2 2018 $107
Q1 2018 $117
Q4 2017 $137
Q3 2017 $147
Q2 2017 $153
Q1 2017 $107
Q4 2016 $126
Q3 2016 $102
Q2 2016 $110
Q1 2016 $99
Q4 2015 $93
Q3 2015 $83
Q2 2015 $90
Q1 2015 $87
Q4 2014 $102
Q3 2014 $100
Q2 2014 $105
Q1 2014 $108
Q4 2013 $64
Q3 2013 $71
Q2 2013 $30
Q1 2013 $30
Q4 2012 $37
Q3 2012 $0
Q2 2012 $0
Q1 2012 $0
Q4 2011 $25
Q4 2010 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.824B $0.107B
NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.152B 27.21
Medtronic (MDT) Ireland $145.746B 20.46
Stryker (SYK) United States $74.888B 25.18
Boston Scientific (BSX) United States $57.453B 27.12
Baxter (BAX) United States $40.896B 24.80
EssilorLuxottica Societe Anonyme (ESLOY) France $32.537B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.730B 18.65
Terumo (TRUMY) Japan $26.750B 33.38
Coloplast (CLPBY) Denmark $25.121B 40.10
Lonza Group Ag (LZAGY) Switzerland $24.554B 0.00
ResMed (RMD) United States $20.727B 38.24
Smith & Nephew SNATS (SNN) United Kingdom $18.483B 0.00
Sunny Optical Technology (SNPTF) China $18.021B 0.00
Insulet (PODD) United States $10.961B 521.47
Bio-Rad Laboratories (BIO) United States $10.558B 50.68
Hill-Rom Holdings (HRC) United States $6.990B 20.59
Canopy Growth (CGC) Canada $6.705B 0.00
William Demant Holdings (WILYY) Denmark $6.665B 0.00
Perrigo (PRGO) Ireland $6.573B 12.26
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.116B 41.33
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.780B 29.76
ICU Medical (ICUI) United States $3.692B 24.08
Aurora Cannabis (ACB) Canada $3.673B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.379B 0.00
Neogen (NEOG) United States $3.366B 56.32
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.995B 0.00
Quidel (QDEL) United States $2.491B 23.64
National Vision Holdings (EYE) United States $2.138B 48.26
Agios Pharmaceuticals (AGIO) United States $2.001B 0.00
Cardiovascular Systems (CSII) United States $1.547B 0.00
InMode (INMD) Israel $1.405B 0.00
VAREX IMAGING (VREX) United States $1.255B 25.13
Aphria (APHA) $1.195B 0.00
AtriCure (ATRC) United States $1.111B 0.00
Phibro Animal Health (PAHC) United States $0.921B 17.24
Lantheus Holdings (LNTH) United States $0.824B 20.58
Eagle Pharmaceuticals (EGRX) United States $0.797B 30.55
TG Therapeutics (TGTX) United States $0.718B 0.00
LeMaitre Vascular (LMAT) United States $0.683B 38.39
Omeros (OMER) United States $0.675B 0.00
PetIQ (PETQ) United States $0.632B 15.45
Quanterix (QTRX) United States $0.628B 0.00
Cerus (CERS) United States $0.601B 0.00
HEXO (HEXO) $0.545B 0.00
Surmodics (SRDX) United States $0.531B 55.44
OraSure Technologies (OSUR) United States $0.507B 30.41
Organigram Holdings (OGI) Canada $0.426B 0.00
Owens & Minor (OMI) United States $0.422B 15.60
MacroGenics (MGNX) United States $0.404B 0.00
Utah Medical Products (UTMD) United States $0.376B 27.22
Meridian Bioscience (VIVO) United States $0.348B 11.98
BioLife Solutions (BLFS) United States $0.338B 138.25
Zynex (ZYXI) United States $0.298B 33.67
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.289B 0.00
Bovie Medical (APYX) United States $0.271B 0.00
Viemed Healthcare (VMD) United States $0.258B 0.00
United Health Products (UEEC) United States $0.214B 0.00
Vapotherm (VAPO) United States $0.200B 0.00
Repro-Med Systems (KRMD) United States $0.174B 0.00
InfuSystems Holdings (INFU) United States $0.144B 0.00
Cytosorbents (CTSO) United States $0.142B 0.00
Fonar (FONR) United States $0.131B 9.24
Liberty Health Sciences (LHSIF) Canada $0.130B 0.00
Rockwell Medical (RMTI) United States $0.125B 0.00
Female Health (VERU) United States $0.125B 0.00
Chimerix (CMRX) United States $0.109B 0.00
United-Guardian (UG) United States $0.088B 22.30
Chembio Diagnostics (CEMI) United States $0.077B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Surface Oncology (SURF) United States $0.047B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.045B 0.00
MTech Acquisition (KERN) United States $0.043B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Senestech (SNES) United States $0.022B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Myomo (MYO) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00